chr15-25355883-A-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP4

This summary comes from the ClinGen Evidence Repository: The allele frequency of the c.2064+9T>C variant in UBE3A is 0.4% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions. Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). In summary, the c.2064+9T>C variant in UBE3A is classified as benign based on the ACMG/AMP criteria (BA1, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA149405/MONDO:0007113/016

Frequency

Genomes: 𝑓 0.0044 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 21 hom. )

Consequence

UBE3A
NM_130839.5 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:11

Conservation

PhyloP100: 0.286

Publications

4 publications found
Variant links:
Genes affected
UBE3A (HGNC:12496): (ubiquitin protein ligase E3A) This gene encodes an E3 ubiquitin-protein ligase, part of the ubiquitin protein degradation system. This imprinted gene is maternally expressed in brain and biallelically expressed in other tissues. Maternally inherited deletion of this gene causes Angelman Syndrome, characterized by severe motor and intellectual retardation, ataxia, hypotonia, epilepsy, absence of speech, and characteristic facies. The protein also interacts with the E6 protein of human papillomavirus types 16 and 18, resulting in ubiquitination and proteolysis of tumor protein p53. Alternative splicing of this gene results in three transcript variants encoding three isoforms with different N-termini. Additional transcript variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
SNHG14 (HGNC:37462): (small nucleolar RNA host gene 14) This gene is located within the Prader-Willi critical region and produces a long, spliced paternally-imprinted RNA that initiates within a common upstream promoter region shared by the SNRPN (small nuclear ribonucleoprotein polypeptide N) and SNURF genes. This transcript serves as a host RNA for the small nucleolar RNA, C/D box 115 and 116 clusters. This RNA extends in antisense into the region of the ubiquitin protein ligase E3A gene (UBE3A), and is thought to regulate imprinted expression of UBE3A in the brain. This transcript undergoes extensive alternative splicing, and may initiate and terminate at multiple locations within this genomic region. The full-length structure of all splice forms is not determined. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130839.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBE3A
NM_130839.5
MANE Select
c.2124+9T>C
intron
N/ANP_570854.1
UBE3A
NM_000462.5
c.2133+9T>C
intron
N/ANP_000453.2
UBE3A
NM_001354505.1
c.2124+9T>C
intron
N/ANP_001341434.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBE3A
ENST00000648336.2
MANE Select
c.2124+9T>C
intron
N/AENSP00000497572.2
UBE3A
ENST00000566215.5
TSL:1
c.2064+9T>C
intron
N/AENSP00000457771.1
SNHG14
ENST00000424333.6
TSL:1
n.5767-62905A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00434
AC:
661
AN:
152170
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0102
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00811
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00442
AC:
1108
AN:
250526
AF XY:
0.00443
show subpopulations
Gnomad AFR exome
AF:
0.000556
Gnomad AMR exome
AF:
0.00663
Gnomad ASJ exome
AF:
0.00577
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00699
Gnomad NFE exome
AF:
0.00544
Gnomad OTH exome
AF:
0.00541
GnomAD4 exome
AF:
0.00425
AC:
6190
AN:
1457940
Hom.:
21
Cov.:
31
AF XY:
0.00420
AC XY:
3044
AN XY:
725522
show subpopulations
African (AFR)
AF:
0.00102
AC:
34
AN:
33366
American (AMR)
AF:
0.00647
AC:
289
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.00510
AC:
133
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39554
South Asian (SAS)
AF:
0.000314
AC:
27
AN:
86120
European-Finnish (FIN)
AF:
0.00736
AC:
393
AN:
53384
Middle Eastern (MID)
AF:
0.00826
AC:
40
AN:
4840
European-Non Finnish (NFE)
AF:
0.00449
AC:
4987
AN:
1109714
Other (OTH)
AF:
0.00477
AC:
287
AN:
60188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
296
592
888
1184
1480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00437
AC:
665
AN:
152284
Hom.:
2
Cov.:
32
AF XY:
0.00481
AC XY:
358
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000794
AC:
33
AN:
41566
American (AMR)
AF:
0.0102
AC:
156
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00811
AC:
86
AN:
10610
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00515
AC:
350
AN:
68014
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00403
Hom.:
2
Bravo
AF:
0.00417
EpiCase
AF:
0.00627
EpiControl
AF:
0.00683

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
1
2
Angelman syndrome (3)
-
-
2
not provided (2)
-
-
1
UBE3A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.3
DANN
Benign
0.75
PhyloP100
0.29
PromoterAI
0.0098
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79328837; hg19: chr15-25601030; API